We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Higher percentages of new cancer drug approvals received priority ratings from the FDA and had orphan drug status during 1999-2018, compared to new non-cancer drugs. Read More
Dr. Reddy’s and Hospira have asked a federal appeals court to reconsider a patent infringement ruling regarding Eli Lilly’s cancer drug Alimta (permetrexed). Read More
States that expanded their Medicaid programs have seen significantly higher numbers of prescriptions of the opioid addiction treatment buprenorphine, according to an analysis by the Urban Institute, a policy think tank in Washington, D.C. Read More